Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Up 12.3% in January

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 436,800 shares, an increase of 12.3% from the January 15th total of 388,900 shares. Based on an average trading volume of 163,900 shares, the short-interest ratio is presently 2.7 days. Approximately 9.3% of the shares of the stock are sold short.

Intelligent Bio Solutions Stock Up 7.6 %

INBS stock traded up $0.18 during mid-day trading on Monday, hitting $2.55. The company had a trading volume of 447,850 shares, compared to its average volume of 166,171. The company has a 50-day moving average price of $1.58 and a 200 day moving average price of $1.55. Intelligent Bio Solutions has a 12-month low of $1.00 and a 12-month high of $5.63.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its earnings results on Thursday, February 13th. The company reported ($0.50) EPS for the quarter. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. The firm had revenue of $610 billion during the quarter. Analysts predict that Intelligent Bio Solutions will post -1.25 EPS for the current fiscal year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.